The Happy Lungs Project Update: July 2024
We are thrilled about the ongoing investment in research supported by the Happy Lungs Project.…
rdsupportJuly 14, 2024
American Society of Clinical Oncology Annual Meeting 2024
The 2024 ASCO Annual Meeting, held May 31-June 4 in Chicago, IL, brought together more…
rdsupportJune 18, 2024
Results From Our Spring 2024 Survey
What we learned, and what’s next: Scientific research can be confusing and overwhelming, and that’s…
rdsupportMay 29, 2024
IASLC Targeted Therapies Recap
#TogetherSeparately: live virtual meetup to summarize data presented on February’s IASLC Targeted Therapies Meeting. March 13 at 3PM…
rdsupportMarch 11, 2024
Looking Ahead: The Future of Diagnostic Testing for Patients
Over the last fifteen years, the introduction of precision medicine has generated renewed hope for…
rdsupportJanuary 7, 2024
2023 RET Cancer Research Update
2023 Happy Lungs Project RET research update On Friday December 8th, the Happy Lungs Project…
rdsupportDecember 18, 2023
Exciting Preclinical Results About Vepafestinib
New published study with exciting preclinical results about the second generation RET inhibitor vepafestinib (TAS0953/HM06). Vepafestinib showed selectivity…
rdsupportOctober 10, 2023
Two research studies funded by HLP presented at 2023 ASCO Mtg
Last week was the 2023 American Society of Clinical Oncology (ASCO) conference in Chicago. The…
rdsupportJune 19, 2023
Ellipses Pharma presents ‘encouraging’ data on selective RET inhibitors
Data of the Phase 1 Study of KL590586 (EP0031/A400), presented at ASCO, reported preliminary efficacy…
rdsupportJune 19, 2023
DAVA’s 2nd Hawaii Global Summit on Thoracic Malignancies
The DAVA’s 2nd Hawaii Global Summit on Thoracic Malignancies is a five-day meeting comprising seven…
rdsupportJune 19, 2023
